1 These agentssuch as semaglutide and tirzepatidedeliver clinically meaningful weight loss, improved glycemic control, and cardiovascular benefit in select populations
Mayo Clinic describes tesamorelin as a hormone similar to the one normally released by the hypothalamus, available only by prescription and given as an injection under the skin of the abdomen (Mayo Clinic tesamorelin overview)
For questions, please call our Member Services by dialing the number on the back of your ID card
Some patients eventually require lower doses of blood pressure medication as their weight and metabolic health improve on GLP-1 therapy, but clinical decisions must remain between you and your doctor
No other GLP-1 medication has the same level of cardiovascular outcome data in people without diabetes
It is an intracellular antioxidant known to maximize the activity of all the other antioxidants, including ascorbic acid, vitamins E and -lipoic acid